Informazioni sul prodotto
- 2-[2-Hydroxy-3-[[2-(1H-indol-3-yl)-1,1-dimethylethyl]amino]propoxy]benzonitrile
- 2-(2-hydroxy-3-{[1-(1H-indol-3-yl)-2-methylpropan-2-yl]amino}propoxy)benzonitrile hydrochloride (1:1)
- <span class="text-smallcaps">DL</span>-Bucindolol hydrochloride
- Benzonitrile, 2-[2-hydroxy-3-[[2-(1H-indol-3-yl)-1,1-dimethylethyl]amino]propoxy]-, hydrochloride (1:1)
- Benzonitrile, 2-[2-hydroxy-3-[[2-(1H-indol-3-yl)-1,1-dimethylethyl]amino]propoxy]-, monohydrochloride
- Bucindolol hydrochloride
- Mj-13105-1
- o-[2-Hydroxy-3-[(2-indol-3-yl-1,1-dimethylethyl)amino]propoxy]benzonitrile monohydrochloride
Bucindolol is a beta-blocker that has been shown to have cardiac, receptor activity, atrial, and myocardial infarct properties. It also has natriuretic peptide levels and biological sample properties. Bucindolol binds to beta-adrenergic receptors in the heart, which leads to decreased heart rate, increased systolic pressure, and relaxation of the papillary muscles. This drug has also been shown to inhibit the production of proprotein convertase subtilisin/kexin type 9 (PCSK9) in vitro.
Proprietà chimiche
Richiesta tecnica su: 3D-FB53609 Bucindolol
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.